Pregnancy in chronic myeloid leukaemia (CML) is no longer precluded. Tyrosine kinase
inhibitors (TKI) have resulted in a life expectancy approaching that of non-leukaemic …

The success of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid
leukaemia (CML) has resulted in a return to a normal life expectancy for the majority of …

Introduction: Since the introduction of tyrosine kinase inhibitors (TKIs) therapy, chronic
myeloid leukemia (CML), has moved from a fatal illness to a manageable disease with a …

With survival expectation that of age-matched controls and given excellent response and
worldwide access to tyrosine kinase inhibitors (TKI), family planning is increasingly …

In considering patients with chronic myeloid leukemia (CML) of child‐bearing age, desiring
the option to plan a family, current tyrosine kinase inhibitor (TKIs) therapy options have …

Since the introduction of tyrosine kinase inhibitors (TKIs) at the beginning of the millennium,
the outlook for patients with chronic myeloid leukemia (CML) has improved remarkably. As …

Abstract Purpose of Review The goal of this review is to summarize what is known about
pregnancy in women with chronic myeloid leukemia (CML): there are very few guidelines …

The article discusses how tyrosine kinase inhibitors (TKIs) has been used for the treatment
of chronic myeloid leukemia (CML). It also talks about the situation of reproductive age in …

TO THE EDITOR: In their recent article in Journal of Clinical Oncology, Berman et al 1 review
pregnancy in patients with chronic myeloid leukemia (CML). Although an uncommon event …

Management of pregnant patients with chronic myelogenous leukemia (CML) is challenging.
Some of the factors that need to be considered include stage of pregnancy, disease status …